Gastro Education 2018
Journal of Clinical Gastroenterology and Hepatology
ISSN: 2575-7733
Page 40
September 06-07, 2018
London, UK
14
th
International Conference on
Gastro Education
N
on-alcoholic fatty liver disease (NAFLD), defined by non-alcohol
related excessive fat accumulation in the liver, is a leading
cause of chronic liver disease worldwide. Obesity is a major risk
factor for NAFLD. Although simple steatosis carries a relatively
benign prognosis, a significant proportion of patients will progress
to non-alcoholic steatohepatitis (NASH). NASH is the advanced
form of NAFLD, leading to liver cirrhosis, end-stage liver disease,
and hepatocellular carcinoma. In this retrospective study, we
analyzed 136 liver samples obtained from patients operated upon
in our surgical department and determined the prevalence of NASH
in relation to gender and body mass index (BMI). Furthermore, we
assessed the association of NASH with the length of the small
bowel measured intraoperatively. Simple steatosis of the liver is
highly prevalent especially in the obese. In our study, we found
steatosis of the liver in more than 80% of morbidly obese patients,
however, probable/definite NASH was found in only 30% of these
patients (and a further 30% of these patients were classified as
uncertain NASH). The exact pathogenesis and natural history are
still being defined. Therapy currently addresses the features of
metabolic syndrome, including diabetes, obesity, and dyslipidemia,
however, if a connection between NASH and small bowel length is
confirmed, malabsorptive bariatric surgery should be considered
as a further option.
Biography
Andreas Hillenbrand graduated from Medical Center of the University of
Munich - LMU Munich in 2000 and started his surgical career in Ulm. After
completing his specialist examination in surgery in 2008, he was focused on
general and endocrine surgery.
andreas.hillenbrand@uniklinik-ulm.dePrevalence of non-alcoholic fatty liver disease in four
different weight related patient groups: association with
small bowel length and risk factors
Andreas Hillenbrand
Ulm University, Germany
Andreas Hillenbrand, J Clin Gastroenterol Hepatol 2018, Volume 2
DOI: 10.21767/2575-7733-C2-006




